May 12, 2025 Sophia Vida
Breaking News

BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results

Preliminary net revenue increased 73% to $72.5 million for Q1 2025, compared to $41.9 million in Q1 2024 Achieved preliminary GAAP net income of $4.5 million, or $0.27 per share Reported preliminary Q1 2025 Adjusted EBITDA of $7.8 million Quarter-end cash balance of $26.7 million, up from $22.8 million as of December 31, 2024 Financial … Continue reading “BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results”